Scientific Industries extends key employment agreements
Scientific Industries Inc. has extended employment agreements for key executives, ensuring leadership stability in the laboratory analytical instruments sector.
Freeport-McMoRan reports third-quarter 2026 results
Freeport-McMoRan provides third-quarter 2026 operational update, showing steady copper and gold production and plans for future growth.
Hub Group announces board restructuring and new appointments
Hub Group, Inc. restructures its board, removing three directors and appointing four new members to enhance governance and strategic direction.
Muzinich Corporate Lending Income Fund sells $3M in stock
Muzinich Corporate Lending Income Fund, Inc. announces a $3 million stock sale, indicating a strategic financial move for the investment fund.
Blue Owl Technology Income Corp. Issues Shareholder Update
Blue Owl Technology Income Corp. shares strong performance in a recent update, highlighting stability in tender results and ongoing distributions through November 2026.
Rivian reports Q3 2026 production and delivery figures
Rivian Automotive announces Q3 2026 production of 19,751 vehicles and delivery of 19,248, reaffirming its annual delivery guidance amid industry competition.
Blue Owl Credit Income reports decline in share repurchase requests
Blue Owl Credit Income Corp. reports a decrease in share repurchase requests, indicating a stabilizing market for the company and the financial services sector.
Thunder Bridge Capital Partners V Announces Trading Changes
Thunder Bridge Capital Partners V, Ltd. allows separate trading of its Class A shares and warrants starting October 5, 2026, enhancing investor liquidity.
Bally's Corp secures $400 million financing for Bronx project
Bally's Corp has closed a $400 million loan to fund its Bronx project, enhancing its position in the hotels and motels industry.
OpenWorld, Inc. amends merger details in SEC filing
OpenWorld, Inc. corrects share issuance details in SEC filing post-merger with Legacy OpenWorld, impacting the finance services sector.
Quince Therapeutics Announces Board Resignations, New Appointments
Quince Therapeutics announces leadership changes with resignations and new appointments ahead of a critical stockholder meeting.
CNS Pharmaceuticals amends equity plan, elects new directors
CNS Pharmaceuticals updates its equity plan and elects new directors at the annual meeting, signaling ongoing growth in the pharmaceutical sector.
Cerenome updates corporate presentation for investors
Cerenome, Inc. updates its corporate presentation, enhancing investor relations and reflecting industry trends in transparency and communication.
Celcuity Inc. Names New CEO Amid Executive Changes
Celcuity Inc. has appointed a new CEO, marking a significant leadership change aimed at enhancing strategic direction and operational efficiency.
EchoStar's DISH DBS Emerges from Bankruptcy, Restructures Debt
EchoStar Corp's subsidiary DISH DBS Corporation has emerged from bankruptcy, completing a significant debt restructuring plan that reduces its liabilities by $4.35 billion.
BNB Plus Corp. shifts focus to blockchain, AI infrastructure
BNB Plus Corp. announces a strategic shift to focus on blockchain and AI infrastructure, aiming to enhance its operational capabilities and market position.
Gorman-Rupp signs new severance agreements for executives
Gorman-Rupp Company has established new severance agreements for its executive team, including the CEO, to enhance retention amid potential changes.
Century Therapeutics Presents Positive Data for CNTY-813
Century Therapeutics shares promising nonclinical data for CNTY-813, an iPSC-derived cell therapy for type 1 diabetes, at the EASD conference.
Surrozen secures FDA clearance for SZN-8141 IND application
Surrozen, Inc. receives FDA clearance for SZN-8141, enabling clinical development for diabetic macular edema, with funding implications.
ASP Isotopes announces merger agreement with ENDRA Life Sciences
ASP Isotopes Inc. has filed an 8-K detailing its merger agreement with ENDRA Life Sciences Inc., potentially reshaping the Miscellaneous Chemical Products industry.